Understanding diabetes risks and prevention in rural areas
Rural Patient Risks and Exposures for Diabetes ConTrol (Rural PREDICT)
This study is looking at what increases the risk of type 2 diabetes in rural areas, so we can create helpful programs to prevent it and make sure everyone has a fair chance at staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11032738 on NIH RePORTER |
What this research studies
This research focuses on identifying the risk factors for type 2 diabetes mellitus (T2DM) in rural populations, where the prevalence of the disease is notably higher than in urban areas. The principal investigator, Dr. Dugani, aims to develop patient-centered interventions to improve the primary prevention of T2DM by utilizing data from the CDC and the Mayo Clinic Biobank. The study will involve a combination of data science, qualitative methods, and health disparities research to create effective strategies tailored for rural communities. By addressing these unique challenges, the research seeks to reduce health disparities related to diabetes in these populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults living in rural areas who are at risk for developing type 2 diabetes.
Not a fit: Patients living in urban areas or those who do not have risk factors for type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies for type 2 diabetes in rural communities, ultimately reducing the incidence of the disease.
How similar studies have performed: Previous research has shown success in addressing health disparities in diabetes care, indicating that targeted interventions can be effective.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Dugani, Chandrasagar — Mayo Clinic Rochester
- Study coordinator: Dugani, Chandrasagar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.